SAMRIDH Impact Accelerator Program 2026
by SAMRIDH Impact Solutions Pvt. Ltd.
Up to Rs. 1 Cr in grant, debt, or equity for healthtech and climate-tech startups at TRL 4+.
- Social impact startups in health, climate or education with TRL 4+ technology at product or revenue stage.
About this scheme
The SAMRIDH Impact Accelerator Program 2026 backs early-to-mid-stage healthcare and climate-tech startups working on solutions with measurable real-world impact. The program is run by SAMRIDH Impact Solutions Pvt. Ltd. (SISPL), a market access and scale-up platform that works with government bodies, development partners, and private ecosystem players to take innovations from validation to scale.
Each selected startup can receive up to Rs. 1 crore in financial support, structured as grant, debt, or equity depending on the venture and stage. The instrument choice gives SISPL flexibility to back companies with the most appropriate capital , non-dilutive grants for proof points, debt for working-capital-heavy pilots, or equity for scaling-stage startups.
On the healthcare side, the program supports diagnostics and screening, digital health, medical devices, software as a medical device (SaMD), elderly and chronic care, critical health system challenges, and health systems strengthening. On the climate side, it supports electric mobility and EV ecosystems, clean energy and climate-resilient infrastructure, climate and environment solutions, and climate-smart agriculture.
Beyond capital, SISPL plugs in pilots with government and institutional partners, clinical and field validation, regulatory pathway and evidence-generation support, public and private channel integration for scale, and connections into investors, donors, and global markets. Applications close on 15 June 2026.
Who can apply
- Early-to-mid-stage Indian startups working in healthcare or climate-tech
- Healthcare focus areas: diagnostics, screening, digital health, medical devices, software as a medical device (SaMD), elderly and chronic care, health systems strengthening
- Climate-tech focus areas: electric mobility and EV ecosystems, clean energy, climate-resilient infrastructure, environmental solutions, climate-smart agriculture
- Technology Readiness Level (TRL) 4 or above
- Early evidence of real-world impact (pilot data, validation, or initial traction)
- Open to startups across India
Benefits & funding
Up to Rs. 1 Cr
- 1 crore per startup, available as grant, debt, or equity depending on stage and capital need.
- SISPL also delivers pilot facilitation with government and institutional partners, clinical and field validation support, regulatory and evidence-generation guidance, public and private channel integration for scale, and access to investors, donors, and global market channels.
How the application process works
The journey below is informational, compiled from the official program guidelines. Applications are submitted directly with SAMRIDH Impact Solutions Pvt. Ltd., in your own name.
- 1
Applications submitted online before 15 June 2026 are evaluated by SISPL on innovation quality, impact potential, and scale-readiness across healthcare and climate-tech sectors.
- 2
Shortlisted startups go through SISPL's internal assessment process before finalizing the financial instrument , grant, debt, or equity , and onboarding terms.
Ready to apply? Get the official link
Applications are submitted directly with SAMRIDH Impact Solutions Pvt. Ltd., in your own name. Share a few details and we will point you to the official application portal and help you prepare a complete submission.
Here is the official application link
Apply in your own name with SAMRIDH Impact Solutions Pvt. Ltd.. Want a second pair of eyes before you submit? An IncorpX advisor can help you prepare.
Open the official applicationFrequently asked questions
How much funding can a startup receive?
Up to Rs. 1 crore per selected startup, structured as grant, debt, or equity depending on stage and capital need.
What stage should the startup be at?
Early-to-mid-stage with a Technology Readiness Level (TRL) of 4 or above and early evidence of real-world impact.
Which sectors are covered?
Healthcare (diagnostics, digital health, medical devices, SaMD, elderly and chronic care, health systems strengthening) and climate-tech (electric mobility, clean energy, climate-resilient infrastructure, environmental solutions, climate-smart agriculture).
What support do startups get beyond funding?
Pilot facilitation with government and institutional partners, clinical and field validation, regulatory and evidence-generation guidance, channel integration for scale, and connections into investors, donors, and global markets.
When is the application deadline?
15 June 2026 is the last date to apply for the 2026 cohort.
IncorpX is a private platform operated by a private company. It is not a government department, agency or official portal, and it is not affiliated with, endorsed by, or acting on behalf of any government body or of any organisation, incubator, accelerator, investor or partner listed in this directory. All program names, logos and trademarks are the property of their respective owners and are used for identification only.
This directory is compiled from publicly available official sources and is provided for general information only. It does not constitute legal, financial, tax or professional advice. Funding amounts, eligibility criteria, required documents, deadlines and availability are determined by each program authority and change with every cycle, so the details shown here may be incomplete or out of date. Always confirm the current terms on the official program source before you apply or take any decision.
IncorpX charges no fee for the information in this directory and does not collect, process, lodge or submit any application on your behalf. Applications are made by you, in your own name, directly with the respective program authority. IncorpX provides assistance only for application preparation and for related registrations such as company incorporation, DPIIT recognition, MSME (Udyam) and GST. Eligibility, approval, disbursement and selection rest solely with the respective program authority, and IncorpX makes no representation or guarantee as to any outcome.
